156 related articles for article (PubMed ID: 27936978)
1. Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.
Lange J; Lenz G; Burkhardt B
Expert Rev Hematol; 2017 Feb; 10(2):123-135. PubMed ID: 27936978
[TBL] [Abstract][Full Text] [Related]
2. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
Egan G; Goldman S; Alexander S
Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
[TBL] [Abstract][Full Text] [Related]
3. Rare mature B-cell lymphomas in children and adolescents.
Woessmann W; Quintanilla-Martinez L
Hematol Oncol; 2019 Jun; 37 Suppl 1():53-61. PubMed ID: 31187530
[TBL] [Abstract][Full Text] [Related]
4. Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
Worch J; Rohde M; Burkhardt B
Pediatr Hematol Oncol; 2013 Sep; 30(6):465-83. PubMed ID: 23570584
[TBL] [Abstract][Full Text] [Related]
5. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
6. Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma.
Gupta S; Alexander S; Pole JD; Sutradhar R; Crump M; Nagamuthu C; Baxter NN; Nathan PC
Br J Haematol; 2022 Feb; 196(3):743-752. PubMed ID: 34599525
[TBL] [Abstract][Full Text] [Related]
7. How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
Lumish M; Falchi L; Imber BS; Scordo M; von Keudell G; Joffe E
J Hematol Oncol; 2021 Jan; 14(1):5. PubMed ID: 33407745
[TBL] [Abstract][Full Text] [Related]
8. Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma.
Dunleavy K
Oncology (Williston Park); 2017 Jun; 31(6):499-501. PubMed ID: 28620906
[TBL] [Abstract][Full Text] [Related]
9. High-grade B-cell lymphoma: how to diagnose and treat.
Novo M; Castellino A; Nicolosi M; Santambrogio E; Vassallo F; Chiappella A; Vitolo U
Expert Rev Hematol; 2019 Jul; 12(7):497-506. PubMed ID: 31150587
[No Abstract] [Full Text] [Related]
10. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
11. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials.
Klapper W; Szczepanowski M; Burkhardt B; Berger H; Rosolowski M; Bentink S; Schwaenen C; Wessendorf S; Spang R; Möller P; Hansmann ML; Bernd HW; Ott G; Hummel M; Stein H; Loeffler M; Trümper L; Zimmermann M; Reiter A; Siebert R;
Blood; 2008 Aug; 112(4):1374-81. PubMed ID: 18509088
[TBL] [Abstract][Full Text] [Related]
13. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma in Adolescents and Young Adults.
Brugières L; Brice P
Prog Tumor Res; 2016; 43():101-14. PubMed ID: 27595360
[TBL] [Abstract][Full Text] [Related]
15. Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.
Sandlund JT; Perkins SL
Br J Haematol; 2015 Jun; 169(5):631-46. PubMed ID: 25851546
[TBL] [Abstract][Full Text] [Related]
16. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
17. High-grade Transformation of Low-grade B-cell Lymphoma: Pathology and Molecular Pathogenesis.
Agbay RL; Loghavi S; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2016 Jan; 40(1):e1-16. PubMed ID: 26658667
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Issa DE; van de Schans SA; Chamuleau ME; Karim-Kos HE; Wondergem M; Huijgens PC; Coebergh JW; Zweegman S; Visser O
Haematologica; 2015 Apr; 100(4):525-33. PubMed ID: 25512643
[TBL] [Abstract][Full Text] [Related]
19. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas.
Soldini D; Georgis A; Montagna C; Schüffler PJ; Martin V; Curioni-Fontecedro A; Martinez A; Tinguely M
Hematol Oncol; 2014 Sep; 32(3):120-5. PubMed ID: 24493312
[TBL] [Abstract][Full Text] [Related]
20. Pathology consultation on intermediate-to-large B-cell lymphomas.
Montgomery ND; Fedoriw Y
Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
